Palomar and Syneron Settlement

Palomar and Syneron Announce Settlement of Patent Infringement Lawsuits

Lou Scafuri, Syneron-Candela CEO: "We are pleased to reach a mutually beneficial settlement that effectively ends the patent disputes between Syneron and Palomar. Syneron has a very strong balance sheet and we believe this fully paid-up license is a strategically beneficial utilization of our cash. It eliminates our exposure to continued legal liability in the matter ... and supports our ongoing efforts to improve the Company's gross and operating margins."

Read Official PR

 

 

 

See more in:

Syneron® manufactures and sells ablative and non-ablative medical aesthetic devices that use the patented elos technology with applications for treatment of wrinkles, skin, age spots, cellulite, acne, rosacea, hair removal, leg veins, spider veins, and much more.  elos technology combines radio frequency and light energies, and is sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.